Karl Dhaene

2.8k total citations · 2 hit papers
30 papers, 2.1k citations indexed

About

Karl Dhaene is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Karl Dhaene has authored 30 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 7 papers in Surgery. Recurrent topics in Karl Dhaene's work include Telomeres, Telomerase, and Senescence (6 papers), Occupational and environmental lung diseases (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Karl Dhaene is often cited by papers focused on Telomeres, Telomerase, and Senescence (6 papers), Occupational and environmental lung diseases (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Karl Dhaene collaborates with scholars based in Belgium, Germany and Czechia. Karl Dhaene's co-authors include Uğur Şahin, Özlem Türeci, Eric Van Marck, Michael Koslowski, Claudio Pasquali, Sergio Pedrazzoli, Fabrizio Michelassi, Günter Klöppel, V. DiCarlo and Renzo Dionigi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Surgery.

In The Last Decade

Karl Dhaene

30 papers receiving 2.0k citations

Hit Papers

Standard Versus Extended Lymphadenectomy Associated With ... 1998 2026 2007 2016 1998 2021 100 200 300 400 500

Peers

Karl Dhaene
Yoshitsugu Mitani United States
Yuriko Mori United States
Nora Joseph United States
Karin D. Berg United States
Ilka Vogel Germany
Karl Dhaene
Citations per year, relative to Karl Dhaene Karl Dhaene (= 1×) peers Hans‐Michael Behrens

Countries citing papers authored by Karl Dhaene

Since Specialization
Citations

This map shows the geographic impact of Karl Dhaene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Dhaene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Dhaene more than expected).

Fields of papers citing papers by Karl Dhaene

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Dhaene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Dhaene. The network helps show where Karl Dhaene may publish in the future.

Co-authorship network of co-authors of Karl Dhaene

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Dhaene. A scholar is included among the top collaborators of Karl Dhaene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Dhaene. Karl Dhaene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Şahin, Uğur, Ö. Türeci, Georgy M. Manikhas, et al.. (2021). FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma. Annals of Oncology. 32(5). 609–619. 244 indexed citations breakdown →
2.
Türeci, Ö., Uğur Şahin, Henning Schulze‐Bergkamen, et al.. (2019). A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study. Annals of Oncology. 30(9). 1487–1495. 161 indexed citations
3.
Şahin, Uğur, Özlem Türeci, Georgy M. Manikhas, et al.. (2019). Zolbetuximab combined with EOX as first-line therapy in advanced CLDN18.2+ gastric (G) and gastroesophageal junction (GEJ) adenocarcinoma: Updated results from the FAST trial.. Journal of Clinical Oncology. 37(4_suppl). 16–16. 16 indexed citations
4.
Pauwels, Patrick, Myriam Remmelink, Delphine Hoton, et al.. (2018). PD-L1 testing for non-small cell lung cancer : Belgian guidelines. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
5.
Pauwels, Patrick, Myriam Remmelink, Delphine Hoton, et al.. (2016). Pathological diagnosis and molecular testing in non-small cell lung cancer: Belgian guidelines. Ghent University Academic Bibliography (Ghent University). 4 indexed citations
6.
Simon, Petra, Tana Omokoko, Andrea Breitkreuz, et al.. (2014). Functional TCR Retrieval from Single Antigen-Specific Human T Cells Reveals Multiple Novel Epitopes. Cancer Immunology Research. 2(12). 1230–1244. 32 indexed citations
7.
Türeci, Özlem, Michael Koslowski, Gerd Helftenbein, et al.. (2011). Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals. Gene. 481(2). 83–92. 79 indexed citations
8.
Koslowski, Michael, Uğur Şahin, Karl Dhaene, Christoph Huber, & Özlem Türeci. (2008). MS4A12 Is a Colon-Selective Store-Operated Calcium Channel Promoting Malignant Cell Processes. Cancer Research. 68(9). 3458–3466. 54 indexed citations
9.
Klamp, Thorsten, Uğur Şahin, Bruno Kyewski, et al.. (2006). Expression profiling of autoimmune regulator AIRE mRNA in a comprehensive set of human normal and neoplastic tissues. Immunology Letters. 106(2). 172–179. 28 indexed citations
10.
Koslowski, Michael, Karl Dhaene, Marleen Praet, et al.. (2005). Expression of multiple epigenetically regulated cancer/germline genes in nonsmall cell lung cancer. International Journal of Cancer. 118(10). 2522–2528. 39 indexed citations
11.
Brusselle, Guy, Guido Van Nooten, Leen Delrue, et al.. (2005). Cor pulmonale and Respiratory Failure in a Young Woman. Respiration. 72(5). 549–551. 6 indexed citations
12.
Smets, Koenraad, et al.. (2004). Neonatal pulmonary interstitial glycogen accumulation disorder. European Journal of Pediatrics. 163(7). 408–9. 18 indexed citations
13.
Dhaene, Karl, Eric Van Marck, & Reza Parwaresch. (2000). Telomeres, telomerase and cancer: an up-date. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 437(1). 1–16. 128 indexed citations
14.
Dhaene, Karl, J. Wauters, Barbara Weyn, Jean‐Pierre Timmermans, & Eric Van Marck. (2000). Expression profile of telomerase subunits in human pleural mesothelioma. The Journal of Pathology. 190(1). 80–85. 23 indexed citations
15.
Dhaene, Karl, J. Wauters, Barbara Weyn, Jean‐Pierre Timmermans, & Eric Van Marck. (2000). Expression profile of telomerase subunits in human pleural mesothelioma. The Journal of Pathology. 190(1). 80–80. 2 indexed citations
16.
Dhaene, Karl, Anja Verhulst, & Eric Van Marck. (1999). SV40 large T-antigen and human pleural mesothelioma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 435(1). 1–7. 21 indexed citations
17.
Dhaene, Karl, et al.. (1999). Diagnosis of Cutaneous T-Cell Lymphoma Detecting T-Cell Receptor γ Chain Gene Monoclonality By Denaturing Gradient Gel Electrophoresis. Acta Clinica Belgica. 54(2). 65–71. 2 indexed citations
18.
Kumar‐Singh, Samir, Werner Jacobs, Karl Dhaene, et al.. (1998). Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcome. The Journal of Pathology. 186(3). 300–305. 93 indexed citations
19.
Pedrazzoli, Sergio, V. DiCarlo, Renzo Dionigi, et al.. (1998). Standard Versus Extended Lymphadenectomy Associated With Pancreatoduodenectomy in the Surgical Treatment of Adenocarcinoma of the Head of the Pancreas. Annals of Surgery. 228(4). 508–517. 523 indexed citations breakdown →
20.
Dhaene, Karl, Richard Hubner, Samir Kumar‐Singh, Barbara Weyn, & Eric Van Marck. (1998). Telomerase activity in human pleural mesothelioma. Thorax. 53(11). 915–918. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026